NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1 – BASIS OF PRESENTATION AND ORGANIZATION

2050 Motors, Inc., (the “Company”) was incorporated on October 9, 2012, in the state of Nevada to import, market, and sell electric cars manufactured in China. On October 25, 2012, 2050 Motors, Inc., entered into an agreement with Jiangsu Aoxin New Energy Automobile Co., Ltd., (“Aoxin”), located in Jiangsu, China, for the distribution in the United States of a new electric automobile, known as the e-Go EV.

Note 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying financial statements were prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”).

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include collectability of accounts receivable, accounts payable, sales returns and recoverability of long-term assets.

Cash

Cash consists of deposits in one large national bank. At March 31, 2018 and December 31, 2017, the Company had $22,136 and $499 in cash in the United States. The Company has not experienced any losses in such accounts and believes it is not exposed to any risks on its cash in bank accounts.

Property, Plant & Equipment

Property, plant and equipment is stated at cost and depreciated using the straight-line method over the estimated useful life of the asset; lease hold improvements are depreciated over the shorter of estimated useful life of the asset or over the lease term. The estimated useful lives of our property and equipment are generally as follows: tools and equipment, five years; vehicles and parts, three years; leasehold improvements, lesser of lease term or life of related asset; and furniture and fixtures, seven years.

As of March 31, 2018 and December 31, 2017, Property, plant and equipment consisted of the following:

Depreciation expense was $6,803 and $9,463 for the three month periods ended March 31, 2018 and 2017, respectively.

Fair Value of Financial Instruments

For certain of the Company’s financial instruments, including cash accounts payable, accrued liabilities, short-term debt and derivative liability, the carrying amounts approximate their fair values due to their short maturities. We adopted ASC Topic 820, “Fair Value Measurements and Disclosures,”, which requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, “Financial Instruments,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of valuation hierarchy are defined as follows:

Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 inputs to the valuation methodology are unobservable in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The Company analyzes all financial instruments with features of both liabilities and equity under ASC 480, “Distinguishing Liabilities from Equity,” and ASC 815.

We have recorded the conversion option on few notes as a derivative liability as a result of the variable conversion price, which in accordance with U.S. GAAP, prevents them from being considered as indexed to our stock and qualified for an exception to derivative accounting.

We recognize derivative instruments as either assets or liabilities on the accompanying balance sheets at fair value. We record changes in the fair value of the derivatives in the accompanying statement of operations.

Assets and liabilities measured at fair value are as follows as of March 31, 2018:

Assets and liabilities measured at fair value are as follows as of December 31, 2017:

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

Earnings Per Share (EPS)

Basic EPS is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted EPS is computed similar to basic net income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if all the potential common shares, warrants and stock options had been issued and if the additional common shares were dilutive. Diluted EPS is based on the assumption that all dilutive convertible shares and stock options were converted or exercised. Dilution is computed by applying the treasury stock method for the outstanding options and the if-converted method for the outstanding convertible preferred shares. Under the treasury stock method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Under the if-converted method, convertible outstanding instruments are assumed to be converted into common stock at the beginning of the period (or at the time of issuance, if later). During the three month periods ended March 31, 2018 and 2017, the Company incurred losses. Therefore, the effect of any common stock equivalents is anti- dilutive during those periods.

The following table sets for the computation of basic and diluted earnings per share for the three month periods ended March 31, 2018 and 2017:

Weighted average number of shares in computing basic and diluted net loss

Revenue Recognition

Revenue Recognition:

The company recognizes revenues when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those good or services. The Company has not generated revenues since inception.

In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry specific guidance. This new standard requires a company to recognize revenues when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. The FASB subsequently issued the following amendments to ASU No. 2014-09 that have the same effective date and transition date: ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations; ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing; ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients; and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers. The Company adopted these amendments with ASU 2014-09 (collectively, the new revenue standards).

The new revenue standards became effective for the Company on January 1, 2018, and were adopted using the modified retrospective method. The adoption of the new revenue standards as of January 1, 2018 did not change the Company’s revenue recognition as the majority of its revenues continue to be recognized when the customer takes control of its product. As the Company did not identify any accounting changes that impacted the amount of reported revenues with respect to its product revenues, no adjustment to retained earnings was required upon adoption.

Cost of Sales

Cost of sales consists primarily of inventory costs, as well as warehousing costs (including the cost of warehouse labor), shipping, importation duties and charges, third party royalties, and product sampling.

Advertising and Marketing Costs

Costs incurred for producing and communicating advertising and marketing are expensed when incurred and included in selling general and administrative expenses. Advertising and marketing expense amounted to $0 and $0 for the three month periods ended March 31, 2018 and 2017, respectively

Operating Overhead Expense

Operating overhead expense consists primarily of payroll and benefit related costs, rent, depreciation and amortization, professional services, and meetings and travel.

Income Taxes

The Company utilizes FASB Accounting Standards Codification (ASC) Topic 740, Income Taxes, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that were included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 provide accounting and disclosure guidance about positions taken by an organization in its tax returns that might be uncertain. When tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statements of income.

At March 31, 2018 and December 31, 2017, the Company had not taken any significant uncertain tax positions on its tax returns for year ended December 31, 2017 and prior years or in computing its tax provision for 2017. Management has considered its tax positions and believes that all of the positions taken by the Company in its Federal and State tax returns are more likely than not to be sustained upon examination. The Company is subject to examination by U.S. Federal and State tax authorities from inception to present, generally for three years after they are filed.

Concentration of Credit Risk

Cash is mainly maintained by one highly qualified institution in the United States. At various times, such amounts are in excess of federally insured limits. Management does not believe that the Company is subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. The Company has not experienced any losses on our deposits of cash.

Risks and Uncertainties

The Company is subject to risks from, among other things, competition associated with the industry in general, other risks associated with financing, liquidity requirements, rapidly changing customer requirements, limited operating history and the volatility of public markets.

Recently Issued Accounting Pronouncements

In February 2016, FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.

Reclassification

Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations or cash flow.

Note 3 – GOING CONCERN

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate the continuation of the Company as a going concern. The Company reported accumulated deficit of $5,550,715 as of March 31, 2018. The Company also had a negative working capital of $2,485,925 and $1,477,483 for the three month periods ended March 31, 2018 and for the year ended December 31, 2017, respectively. To date, these losses and deficiencies have been financed principally through the issuance of common stock, loans from related parties and from third parties.

In view of the matters described, there is substantial doubt as to the Company’s ability to continue as a going concern without a significant infusion of capital. We anticipate that we will have to raise additional capital to fund operations over the next 12 months. To the extent that we are required to raise additional funds to acquire properties, and to cover costs of operations, we intend to do so through additional offerings of debt or equity securities. There are no commitments or arrangements for other offerings in place, no guaranties that any such financings would be forthcoming, or as to the terms of any such financings. Any future financing will involve substantial dilution to existing investors.

Note 4 – VEHICLE DEPOSITS

Vehicle deposit of $24,405, as of March 31, 2018 and December 31, 2017, represents one prototype test model for delivery into the United States when the specifications are completed for an advanced crash test known in the Automobile Safety Industry as the “overlap crash test”. The estimated date set for this test is mid-2018.

Note 5 – LICENSE AGREEMENT

In 2012 and 2013, the Company made a total payment of $50,000 and signed an exclusive license agreement with Aoxin to import, assemble and manufacture the advanced carbon fiber electric vehicle, the e-Go EV model. The cost of this license agreement has been recognized as a long-term asset and is evaluated, by management, for impairment losses at each reporting period. As of March 31, 2018 and December 31, 2017, impairment losses of $50,000 and 0, respectively, have been identified by the management.

Note 6 – LOANS PAYABLE DUE TO RELATED PARTIES

On July 1, 2017, the Company entered into an unsecured loan payable agreement with a related party for $14,100, due on September 15, 2017. The Company granted the related party an option to purchase up to 1,000,000 shares of common stock at an exercise price of $0.015 per share. The fair market value of the options was $26,746. A debt discount of $14,100 was amortized over the term of the loan. The Company also agreed to pay $1,500 as an interest on the loan. On September 27, 2017, the Company entered into a note amendment, whereby, the term of the note was extended until November 1, 2017, in exchange for an additional $1,500 finance fee and $1,500 late fee. The Company recorded the same as interest expense. As of March 31, 2018, the loan is in default and the outstanding balance of the loan, as of March 31, 2018 and December 31, 2017 was $17,100. The Company accrued a penalty interest of $1,750 plus $100 per day of default totaling $25,968 and $16,698 as of March 31, 2018 and December 31, 2017, respectively. Interest expense for the three months ended March 31, 2018 and 2017 was $9,000 and $0, respectively. In accordance with ASC 815, one million options were reclassified from equity to derivative liabilities with a fair value of $4,300 and a derivative loss of $9,800.

On September 27, 2017, the Company entered into another unsecured loan payable agreement with the same related party for $17,500, due on November 1, 2017. The loan holder charged $1,750 as funding fee and $1,650 as processing fee for the loan, which were recorded as debt discount, with net loan proceeds of $14,100. The Company also granted the related party an option to purchase up to 1,000,000 shares of common stock at an exercise price of $0.015 per share. The fair market value of the options was $22,945. The Company amortized the debt discount of $14,100 and the finance fee of $3,400, over the term of the loan. In accordance with ASC 815, one million options were reclassified from equity to derivative liabilities with a fair value of $5,800 and a derivative loss of $8,300. As of March 31, 2018, the loan is in default and the outstanding balance of the loan, as of March 31, 2018 and December 31, 2017 was $17,500. The Company accrued a penalty interest of $1,750 plus $100 per day of default totaling $23,100 and $14,100 as of March 31, 2018 and December 31, 2017, respectively. Interest expense for the three months ended March 31, 2018 and 2017 was $9,000 and $0, respectively. During the three month periods ended March 31, 2018 and 2017, the Company accrued $9,000 and $0 as a penalty in the accompanying financial statements.

The Company determined the derivative liability of the options using the Binomial model. The variables used for the Binomial model are as listed below:

The Company received an unsecured $10,000 loan during the third quarter of 2016 from a related party. The loan bears 12% interest and on March 16, 2017, the original maturity date, an extension was granted to April 1, 2018. The outstanding balance on the loan as of March 31, 2018 and December 31, 2017 was $10,000. The Company recorded accrued interest of $1,845 and $1,549 as of March 31, 2018 and December 31, 2017, respectively. Interest expense for the three months ended March 31, 2018 and 2017 was $296 and $0, respectively.

Note 7 – CONVERTIBLE NOTE PAYABLES

On April 25, 2017, the Company entered into a note amendment whereby, the maturity of the note was extended to January 26, 2018 and the principal was increased by $7,800 to $72,800. The Company wired $33,118 to the note holder as loan extension fee. The additional finance fee of $7,800 was amortized over the remaining term of the note.

During the year ended December 31, 2017, the note holder converted $23,600 of the note pursuant to two separate conversion notices. The Company issued 2,911,195 shares of common stock to effect the conversions and recorded a loss on debt settlement of $5,786 for the shares issued in excess of the agreed conversion price.

During the three month period ended March 31, 2018, the note holder converted $32,286 of the principal of the note, pursuant to four separate conversion notices into 12,681,921 shares of common stock to effect the conversions and recorded a loss on debt settlement of $6,902 for the difference with the agreed conversion price. The derivative liability of $114,796, related to the converted portion, was reclassed to additional paid in capital.

The note was due on January 26, 2018 and is currently in default. All remaining finance fee and debt discount were amortized over the term of the note. The derivative liability for the remaining note was recalculated on March 31, 2018 to be $101,479. The change in derivative liability of $41,343 was recorded on the accompanying financial statements.

The Company amortized a debt discount of $4,202 and $18,500, respectively, during the three month periods ended March 31, 2018 and 2017. The Company amortized the finance fee of $2,869 and $3,167, respectively, during the three month periods ended March 31, 2018 and 2017. Interest expense totaled $951 and $1,950 respectively, during the three month periods ended March 31, 2018 and 2017. As of March 31, 2018 and December 31, 2017, the outstanding balance on the convertible note payable amounted to $16,913 and $49,200, respectively. Accrued interest totaled $10,464 and $9,513 as of March 31, 2018 and December 31, 2017, respectively. Subsequent to March 31, 2018, the note holder converted $6,871 of the principal balance into 4,580,800 shares of common stock.

On June 30, 2017, the Company entered into a note amendment agreement to increase the principal balance of the note by $14,100 to $92,850. The Company paid the $14,100 to the holder on July 6, 2017, to delay conversion option until September 5, 2017, pursuant to the amended terms. On September 27, 2017, the Company entered into another note amendment agreement to increase the principal balance of the note by $21,100 to $99,850. The Company wired $14,100 on September 27, 2017, to reduce the principal balance of the note to $85,750. The note holder effected conversion of accrued interest of $7,006 into 1,946,000 shares of common stock. The Company recorded a loss on debt settlement of $34,837 for the shares issued in excess of the agreed conversion price.

During the three month period ended March 31, 2018, the note holder converted $12,319 of the note plus unpaid accrued interest of $9,351, pursuant to four separate conversion notices into 14,501,000 shares of common stock to effect the conversions and recorded a loss on debt settlement of $5,700 for the difference with the agreed conversion price. The derivative liability of $53,104, related to the converted portion, was reclassed to additional paid in capital.

The note was due on February 6, 2018 and is currently in default and a default penalty of $35,000 was added to the note principal as of the issue date for a total of $113,750. As of March 31, 2018, the outstanding principal and interest was $109,943 which includes a default interest rate of 22%. The Company accrued additional penalties and interest of approximately $264,000 related to the breach of covenants. All remaining finance fee and debt discount were amortized over the term of the note. The derivative liability for the remaining note was recalculated on March 31, 2018 to be $1,221,589. The change in derivative liability of $905,047 was recorded on the accompanying financial statements.

The Company amortized a debt discount of $534 and $21,538, respectively, during the three month periods ended March 31, 2018 and 2017. The Company amortized the finance fee of $5,246 and $2,692, respectively, during the three month periods ended March 31, 2018 and 2017. Interest expense totaled $4,401 and $2,175 respectively, during the three month periods ended March 31, 2018 and 2017. As of March 31, 2018 and December 31, 2017, the outstanding principal and interest on the convertible note payable amounted to $109,943 and $85,750, respectively. Subsequent to March 31, 2018, the note holder converted $1,898 of the principal balance and $1,460 of the accrued interest into 4,664,900 shares of common stock.

During the year ended December 31, 2017, the note holder converted $35,000 of the note for 4,106,274 shares of common stock. The Company recorded a gain on settlement of $1,528, for the difference in the conversion price.

During the three month period ended March 31, 2018, the note holder converted balance $23,000 of the note plus unpaid accrued interest of $3,480, pursuant to three separate conversion notices. The Company issued 5,375,889 shares of common stock to effect the conversions and recorded a gain on debt settlement of $2,079 for the difference with the agreed conversion price. The remaining finance fee of $191 and remaining debt discount of $2,323 was amortized on the conversion of the note. The related derivative liability of $21,366 was reclassed to additional paid in capital on the conversion of the note.

The Company amortized a debt discount of $2,323 and $0 during the three month periods ended March 31, 2018 and 2017. The Company amortized the finance fee of $191 and $0, respectively, during the three month periods ended March 31, 2018 and 2017. Interest expense was $0 respectively, during the three month periods ended March 31, 2018 and 2017. As of March 31, 2018 and December 31, 2017, the outstanding balance on the convertible note payable amounted to $0 and $23,000, respectively.

The derivative liability was recalculated on March 31, 2018 as $42,983 and the difference in the value was recorded as a change in derivative liability in the income statement. The Company amortized a debt discount of $5,798 during the three month period ended March 31, 2018. The Company amortized the finance fee of $155 during three month period ended March 31, 2018. Interest expense of $568 was accrued on the convertible note during the three month period ended March 31, 2018. As of March 31, 2018, the balance outstanding on the loan was $19,181 plus accrued interest of $870. The loan is due on August 30, 2018.

The variables used for the Binomial model are as listed below:

During the three month period ended March 31, 2018, the note holder converted $4,198 of the note principal balance, pursuant to a conversion notice into 4,664,000 shares of common stock to effect the conversions and recorded a loss on debt settlement of $8,480 for the difference with the agreed conversion price. The related debt discount of $2,670 and related finance fee of $297 were also amortized. The related derivative liability on the converted portion of the note of $10,006 was reclassed as additional paid in capital on the note conversion. In accordance with ASC 815, 250,000 warrants were reclassified from equity to derivative liabilities with a fair value of $1,100 and a derivative loss of $13,600.

The derivative liability was recalculated on March 31, 2018 as $52,791 and the difference in the value was recorded as a change in derivative liability in the income statement. The Company amortized additional debt discount of $3,263 during the three month period ended March 31, 2018. The Company amortized additional finance fee of $363 during the three month period ended March 31, 2018. Interest expense was $612 for the three month period ended March 31, 2018. As of March 31, 2018 and December 31, 2017, the balance outstanding on the loan was $20,802 and $25,000, respectively. Accrued interest was $1,340 and $728 as of March 31, 2018 and December 31, 2017, respectively. The loan is due on September 15, 2018.

The variables used for the Binomial model are as listed below:

Subsequent to March 31, 2018, the note holder converted $7,903 of the principal balance into 10,977,000 shares of common stock.

The derivative liability was recalculated on March 31, 2018 as $165,600 and the difference in the value was recorded as a change in derivative liability in the income statement. The Company amortized a debt discount of $6,164 during the three month ended March 31, 2018. The Company amortized the finance fee of $493 during the three month ended March 31, 2018. Interest expense was $799 for the three month ended March 31, 2018. As of March 31, 2018 and December 31, 2017, the balance outstanding on the loan was $27,000. Accrued interest was $1,216 and $417 at March 31, 2018 and December 31, 2017, respectively. The loan is due on November 14, 2018.

The variables used for the Binomial model are as listed below:

The derivative liability was recalculated on March 31, 2018 as $82,353 and the difference in the value was recorded as a change in derivative liability in the income statement. The Company amortized a debt discount of $7,806 during the three month period ended March 31, 2018. The Company amortized the finance fee of $473 during three month period ended March 31, 2018. Interest expense of $759 was accrued on the convertible note during the three month period ended March 31, 2018. As of March 31, 2018, the balance outstanding on the loan was $35,000.

The variables used for the Binomial model are as listed below:

The derivative liability was recalculated on March 31, 2018 as $103,585 and the difference in the value was recorded as a change in derivative liability in the income statement. The Company amortized a debt discount of $5,267 during the three month period ended March 31, 2018. The Company amortized the finance fee of $395 during three month period ended March 31, 2018. Interest expense of $523 was accrued on the convertible note during the three month period ended March 31, 2018. As of March 31, 2018, the balance outstanding on the loan was $43,000.

The variables used for the Binomial model are as listed below:

During the year ended December 31, 2017, the related party assigned $30,000 of the loan to an unrelated third party on the same terms. The third party opted to convert $5,000 of the principal balance into 892,857 shares of common stock of the Company. The Company recorded a loss on settlement of debt of $714, on the excess shares issued to the note holder. The derivative liability was recalculated on December 31, 2017 as $62,222 on the loan assigned and the proportionate difference in the value was recorded as a change in derivative liability in the income statement.

The derivative liability was recalculated on March 31, 2018 as $65,000 and the difference in the value recorded as a change in derivative liability in the income statement. The Company amortized a debt discount of $1,461 during the three month period ended March 31, 2018. Interest expense was $740 for the three month period ended March 31, 2018. As of March 31, 2018 and December 31, 2017, the balance outstanding on the loan was $25,000. Accrued interest was $4,340 and $3,600 as of March 31, 2018 and December 31, 2017, respectively. The loan was due on June 30, 2018 and as of the date of these financials remains unpaid.

Note 8 – COMMITMENTS AND CONTINGENCIES

Effective March 1, 2014, the Company signed a lease for four thousand square feet of industrial space in North Las Vegas. The term of the lease is for three years and cost $2,200 per month. The lease expired on April 30, 2017 and the Company is now on a month to month lease Rent expense amounted to $6,800 and $6,417 for the three month periods ended March 31, 2018 and 2017, respectively.

According to the license agreement signed between the Company and Aoxin, in order to maintain exclusive rights for the United States (US), the Company is required to purchase and sell certain amount of e-Go EV model vehicles per year for a certain period of time starting from the completion of the requirements established by the United States Department of Transportation’s protocols for the e-Go EV model. The table below demonstrates the required amount of vehicles that the company needs to sell per year.

As part of the license agreement, the Company is committed to pay expenses related to any required airbag testing procedures. The cost of these airbags could be as little as $500,000 or as much as $2 million.

The Company may from time to time, become a party to various legal proceedings, arising in the ordinary course of business. The Company investigates these claims as they arise. Management does not believe, based on current knowledge, that there were any such claims outstanding as of March 31, 2018.

Note 9 – REVOLVING LINE OF CREDIT- RELATED PARTY

On February 12, 2016, the Company signed a twelve months revolving line of credit agreement with a related party. The line amount is $100,000 and carries interest at 12% per annum. In January 2017, the Company signed an amendment to extend the due date of the loan to June 30, 2018 for a conversion option for the restricted common stock of the Company. The note carries interest at the rate of 12% per annum and is convertible at any time starting from January 18, 2017 and ending on the later of the maturity date or the date of payment. The note is convertible at 50% of the Average Market Price for the 15 previous trading days before the conversion notice date. The derivative liability on the note was calculated, using the Binomial model, to be $227,760, of which $101,400 was recorded as a debt discount and the balance $126,360 was recorded as an interest expense, at inception.

During the year ended December 31, 2017, the related party assigned $30,000 of the loan to an unrelated third party on the same terms. The derivative liability was recalculated on December 31, 2017 as $177,707 on the balance related party loan and the difference in the value recorded as a change in derivative liability in the income statement.

During the three month period ended March 31, 2018, the Company paid off $10,542 of the principal balance and $1,458 of the accrued interest. The Company raised additional cash of $12,000 on the line of credit on the same terms. The derivative liability on the new money raised was calculated, using the Binomial model, to be $21,691, of which $12,000 was recorded as a debt discount and the balance $9,688 was recorded as an interest expense, at inception.

The derivative liability was recalculated on March 31, 2018 as $213,050 and the difference in the value recorded as a change in derivative liability in the income statement. The Company amortized a debt discount of $14,430 during the three month period ended March 31, 2018. Interest expense of $2,097 was accrued on the convertible loan during the three month period ended March 31, 2018. As of March 31, 2018 and December 31, 2017, the balance outstanding on the loan was $69,942 and $81,942, respectively. Accrued interest was $9,207 and $8,568 as of March 31, 2018 and December 31, 2017, respectively. The loan was due on June 30, 2018 and remains unpaid.

Subsequent to March 31, 2018, the loan holder converted $60,000 of the principal balance into 24,000,000 shares of common stock.

Note 10 – INCOME TAXES

The Company did not file its federal tax returns for fiscal years from 2012 through 2017. Management believes that it should not have any material impact on the Company’s financials because the Company did not have any tax liabilities due to net loss incurred during these years.

Based on the available information and other factors, management believes it is more likely than not that the net deferred tax assets at March 31, 2018 and December 31, 2017 will not be fully realizable. Accordingly, management has recorded a full valuation allowance against its net deferred tax assets at March 31, 2018 and December 31, 2017. At March 31, 2018 and December 31, 2017, the Company had federal net operating loss carry-forwards of approximately $4,000,000, expiring beginning in 2032.

Deferred tax assets consist of the following components:

Note 11 – EQUITY

During the year ended December 31, 2016, the Company agreed to issue 3,200,000 shares for services at a price between $0.157 to $0.075, for a total of $256,480. Additionally, the Company agreed to issue 825,000 shares of common stock for marketing services at a per share price of $0.1497 for a total consideration of $125,000. As of March 31, 2018, these shares are yet to be issued and have been recorded as common stock issuable.

The Company also agreed to issue 200,000 shares of its common stock at $0.05 per share for $10,000 cash, during the year ended December 31, 2016. The shares were issued during the year ended December 31, 2017.

On June 24, 2016, the Company issued a $75,000 non-refundable Promissory Note to an investor as a pre- condition to an Equity Purchase Agreement. The promissory note bears 10% interest per annum with a one year maturity date. This note resulted in a $75,000 deferred equity issuance cost and is being amortized over the contract period. During the year ended December 31, 2017 and 2016, respectively, the Company recorded $37,500 and $18,750 in amortization of the deferred equity issuance costs for the Equity Purchase Agreement (See Note 13). During the year ended December 31, 2017, the Company issued 1,500,000 shares for the conversion of the promissory note along with interest accrued on the same of $6,574. The shares issued were recorded at the fair market value of $0.054 on the date of conversion notice.

During the year ended December 31, 2017, the Company increased the authorized share capital for common stock of the Company from 100 million to 300 million. During the year ended December 31, 2017, the Company increased the authorized share capital for preferred stock of the Company from 0 to 10 million.

During the year ended December 31, 2017, the Company issued 36,885 shares of company’s common stock, to a third party for $2,250 cash.

During the year ended December 31, 2017, the Company issued 140,808 shares of company’s common stock, for payment of a related party accounts payable totaling $8,589, including penalties.

During the year ended December 31, 2017, the Company issued 177,694 shares of company’s common stock in exchange for consulting and advisory services, valued at $10,840.

During the year ended December 31, 2017, the Company issued 2,911,195 shares of company’s common stock, to partially convert $23,600 of a convertible note payable.

During the year ended December 31, 2017, the Company issued 1,946,200 shares of common stock to effect conversion of accrued interest on a convertible note of $7,006.

During the year ended December 31, 2017, one of the note holder converted $35,000 of the note for 3,106,274 shares of common stock.

During the year ended December 31, 2017, the Company issued 892,857 shares of company’s common stock, to partially convert $5,000 of a convertible note payable.

During the year ended December 31, 2017, the Company agreed to issue 1,000,000 shares of common stock to a third party for $15,000 cash. The shares were not issued as of December 31, 2017 and have been recorded as shares to be issued in the accompanying financial statements.

During the year ended December 31, 2017, the Company capitalized $48,000 as capital contribution by prior president of the Company, for the accrued salary due to the prior president.

During the year ended December 31, 2017, the Company entered into an unsecured loan payable agreement with a related party for $14,100, due on September 15, 2017. The Company granted the related party an option to purchase up to 1,000,000 shares of common stock at an exercise price of $0.015 per share. The Company valued the options using the black scholes options pricing model. The fair market value of the options was $26,746. The value was restricted to the face value of the note and hence, $14,100 was recorded as a debt discount and credited as additional paid in capital in the accompanying financials (See Note 7).

During the year ended December 31, 2017, the Company entered into another unsecured loan payable agreement with the same related party for $17,500, with net loan proceeds of $14,100. The Company also granted the related party an option to purchase up to 1,000,000 shares of common stock at an exercise price of $0.015 per share. The Company valued the options using the black scholes options pricing model. The fair market value of the options was $22,945. The value was restricted to the net proceeds of the note and hence, $14,100 was recorded as a debt discount and credited as additional paid in capital in the accompanying financials (See Note 7).

During the year ended December 31, 2017, the Company entered into an unsecured convertible note agreement with a third party for $25,000. The Company received $22,500, net of the financing fee of $2,500. The Company also granted a warrant with the convertible note to buy 250,000 shares of common stock of the Company at an exercise price of $0.10 per share. The Company valued the warrants using the black scholes option pricing model at $14,700, which was recorded as a debt discount and credited as additional paid in capital in the accompanying financials (See Note 7).

During the three month ended March 31, 2018, the Company increased the authorized share capital of the Company from 300 million to 1 billion shares of common stock.

During the three month ended March 31, 2018, the Company issued 3 million shares of preferred stock to the prior president of the Company for services rendered during the quarter. A value of $45,000 was recorded in these financial statements.

During the three month period ended March 31, 2018, the Company issued 54,954,114 shares of common stock to effect the conversions of various convertible note payables and accrued interest on same and recorded a loss on debt settlement of $16,734 for the difference with the agreed conversion price.

Note 12 – WARRANTS AND OPTIONS

As of March 31, 2018, there were 2,000,000 options outstanding and exercisable, issued in relation with loans payable due to related parties. Each whole share purchase option has an exercise price of $0.015 per common share. The options were evaluated for purposes of classification between liability and equity and were reclassed from equity to derivative liability. The Binomial model was used to estimate the fair value of $10,100 for the options. Following inputs were used for the Binomial model:

Activity for the year ended December 31, 2017 and the three month period ended March 31, 2018 is as follows:

As of March 31, 2018, there were 250,000 warrants outstanding and exercisable, issued in relation with a convertible note payable. Each whole share purchase option has an exercise price of $0.10 per common share. The warrants were evaluated for purposes of classification between liability and equity. The warrants contain features that would require a liability classification and are therefore recorded as derivative liability. The Binomial model was used to estimate the fair value of $1,100 for the Warrants. Following inputs were used for the Binomial model:

Activity for the year ended December 31, 2017 and the three months ended March 31, 2018 is as follows: